Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 28, 2023
Patent Application Number
16986770
Date Filed
August 6, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
Disclosed herein are antisense compounds and methods for decreasing Tau mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate Tau-associated diseases, disorders, and conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
